Impact of cardiovascular risk factors on the clinical presentation and survival of pulmonary embolism without identifiable risk factor

被引:10
作者
Rodriguez-Nunez, Nuria [1 ]
Ruano-Ravina, Alberto [2 ,3 ]
Lama, Adriana [1 ]
Ferreiro, Lucia [1 ,4 ]
Ricoy, Jorge [1 ]
Alvarez-Dobano, Jose M. [1 ,4 ]
Suarez-Antelo, Juan [1 ]
Elena Toubes, M. [1 ]
Rabade, Carlos [1 ]
Golpe, Antonio [1 ,4 ]
Lourido, Tamara [1 ]
Javier Gonzalez-Barcala, Francisco [1 ,4 ]
Valdes, Luis [1 ,4 ]
机构
[1] Complejo Hosp Univ Santiago, Dept Pulmonol, Santiago De Compostela, Spain
[2] Univ Santiago de Compostela, Dept Prevent Med & Publ Hlth, Santiago De Compostela 15782, Spain
[3] CIBERESP, CIBER Epidemiol & Publ Hlth, Madrid, Spain
[4] Inst Invest Sanitarias Santiago IDIS, Interdisciplinary Res Grp Pulmonol, Santiago De Compostela, Spain
关键词
Pulmonary embolism (PE); unprovoked pulmonary embolism (unprovoked PE); no identifiable risk factor (no IRF); venous thromboembolism; cardiovascular risk factors (CVRFs); severity; mortality; UNPROVOKED VENOUS THROMBOEMBOLISM; THROMBOSIS; DIAGNOSIS; ATHEROSCLEROSIS; EPIDEMIOLOGY; METAANALYSIS; ASSOCIATION; SEVERITY; EVENTS; INDEX;
D O I
10.21037/jtd-20-1634
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: The nature of pulmonary embolism (PE) without identifiable risk factor (IRF) remains unclear. The objective of this study is to investigate the potential relationship between cardiovascular risk factors (CVRFs) and PE without IRF (unprovoked) and assess their role as markers of disease severity and prognosis. Methods: A case-control study was performed of patients with PE admitted to our hospital [2010-2019]. Subjects with PE without IRF were included in the cohort of cases, whereas patients with PE with IRF were allocated to the control group. Variables of interest included age, active smoking, obesity, and diagnosis of arterial hypertension, dyslipidemia or diabetes mellitus. Results: A total of 1,166 patients were included in the study, of whom 64.2% had PE without IRF. The risk for PE without IRF increased with age [odds ratio (OR): 2.68; 95% confidence interval (CI): 1.95-3.68], arterial hypertension (OR: 1.63; 95% CI: 1.27-2.07), and dyslipidemia (OR: 1.63; 95% CI: 1.24-2.15). The risk for PE without IRF was higher as the number of CVRF increased, being 3.99 (95% CI: 2.02-7.90) for subjects with >= 3 CVRF. The percentage of high-risk unprovoked PE increased significantly as the number of CVRF rose [0.6% for no CVRF; 23.8% for a CRF, P<0.001 (OR: 9.92; 95% CI: 2.82-34.9); 37.5% for two CRFs, P<0.001 (OR: 14.8; 95% CI: 4.25-51.85); and 38.1% for >= 3, P<0.001 (OR: 14.1; 95% CI: 4.06-49.4)]. No significant differences were observed in 1-month survival between cases and controls, whereas differences in 24-month survival reached significance. Conclusions: A relationship was observed between CVRF and PE without IRF, as the risk for unprovoked PE increased with the number of CVRF. In addition, the number of CVRF was associated with PE without IRF severity, but not with prognosis.
引用
收藏
页码:5411 / 5419
页数:9
相关论文
共 42 条
[1]   Cardiovascular risk factors and venous thromboembolism - A meta-analysis [J].
Ageno, Walter ;
Becattini, Cecilia ;
Brighton, Timothy ;
Selby, Rita ;
Kamphuisen, Pieter W. .
CIRCULATION, 2008, 117 (01) :93-102
[2]  
[Anonymous], 2019, Rev Esp Cardiol (Engl Ed), V72, P160, DOI 10.1016/j.rec.2018.12.004
[3]   Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study [J].
Baglin, T ;
Luddington, R ;
Brown, K ;
Baglin, C .
LANCET, 2003, 362 (9383) :523-526
[4]   A prospective study on cardiovascular events after acute pulmonary embolism [J].
Becattini, C ;
Agnelli, G ;
Prandoni, P ;
Silingardi, M ;
Salvi, R ;
Taliani, MR ;
Poggio, R ;
Imberti, D ;
Ageno, W ;
Pogliani, E ;
Porro, F ;
Casazza, F .
EUROPEAN HEART JOURNAL, 2005, 26 (01) :77-83
[5]   Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism [J].
Brighton, Timothy A. ;
Eikelboom, John W. ;
Mann, Kristy ;
Biostat, M. ;
Mister, Rebecca ;
Gallus, Alexander ;
Ockelford, Paul ;
Gibbs, Harry ;
Hague, Wendy ;
Xavier, Denis ;
Diaz, Rafael ;
Kirby, Adrienne ;
Simes, John .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (21) :1979-1987
[6]  
Catapano AL, 2017, REV ESP CARDIOL, V70, pe1
[7]   ADAPTING A CLINICAL COMORBIDITY INDEX FOR USE WITH ICD-9-CM ADMINISTRATIVE DATABASES [J].
DEYO, RA ;
CHERKIN, DC ;
CIOL, MA .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) :613-619
[8]   Serum lipid levels and the risk of venous thrombosis [J].
Doggen, CJM ;
Smith, NL ;
Lemaitre, RN ;
Heckbert, SR ;
Rosendaal, FR ;
Psaty, BM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (10) :1970-1975
[9]   A novel role for CD36 in VLDL-enhanced platelet activation [J].
Englyst, NA ;
Taube, JM ;
Aitman, TJ ;
Baglin, TP ;
Byrne, CD .
DIABETES, 2003, 52 (05) :1248-1255
[10]   Increased risk and severity of unprovoked venous thromboembolism with clustering cardiovascular risk factors for atherosclerosis: Results of the REMOTEV registry [J].
Gaertner, S. ;
Cordeanu, E. -M. ;
Mirea, C. ;
Frantz, A. -S. ;
Auger, C. ;
Bilbault, P. ;
Ohlmann, P. ;
Schini-Kerth, V. ;
Stephan, D. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 252 :169-174